Proceedings: Effect of amantadine on the urinary excretion of some monoamines and metabolites in normal and parkinsonian subjects.
D000547:Amantadine / Q000494:pharmacology* / Q000627:therapeutic use; D000588:Amines / Q000652:urine*; D004295:Dihydroxyphenylalanine / Q000627:therapeutic use; D004298:Dopamine / Q000652:urine; D004837:Epinephrine / Q000652:urine; D006632:Histamine / Q000652:urine; D006719:Homovanillic Acid / Q000652:urine; D006801:Humans; D006897:Hydroxyindoleacetic Acid / Q000652:urine; D009638:Norepinephrine / Q000652:urine; D010300:Parkinson Disease / Q000188:drug therapy / Q000652:urine*; D010648:Phenylacetates / Q000652:urine
D000588:Amines; D010648:Phenylacetates; D006897:Hydroxyindoleacetic Acid; D004295:Dihydroxyphenylalanine; D006632:Histamine; D000547:Amantadine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid; D004837:Epinephrine